Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03383978
Title Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab in Patients With Recurrent HER2-positive Glioblastoma (CAR2BRAIN)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Johann Wolfgang Goethe University Hospital
Age Groups: adult | senior
Covered Countries DEU

No variant requirements are available.